Fluconazole prophylaxis in preterm infants: a systematic review

Brazilian Journal of Infectious Diseases

Volumn 21, Issue 3, 2017, Pages 333-338

  Rios, Juliana Ferreira da Silva ^a   Camargos, Paulo Augusto Moreira ^a   Corrêa, Luísa Petri ^a   Romanelli, Roberta Maia de Castro ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antifungal; Candida; Fluconazole prophylaxis; Preterm infants

Indexed keywords

FLUCONAZOLE; PLACEBO; ANTIFUNGAL AGENT;

ANTIBIOTIC PROPHYLAXIS; CANDIDA; DRUG EFFICACY; DRUG USE; FUNGAL COLONIZATION; HUMAN; INVASIVE CANDIDIASIS; MORTALITY RATE; NONHUMAN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; CANDIDIASIS, INVASIVE; INFANT, PREMATURE, DISEASES; NEWBORN;

ANTIFUNGAL AGENTS; CANDIDIASIS, INVASIVE; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES;

EID: 85016168583     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2017.01.008     Document Type: Review

References (43)

1. McCrossan, B.A., McHenry, E., O'Neill, F., Ong, G., Sweet, D.G., Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection. Arch Dis Child Fetal Neonatal Ed 92 (2007), F454–F458.
2. Manzoni, P., Farina, D., Leonessa, M., et al. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118 (2006), 2359–2364.
3. Greenberg, R.G., Benjamin, D.K. Jr., Neonatal candidiasis: diagnosis, prevention, and treatment. J Infect 69:Suppl. 1 (2014), S19–S22.
4. Kelly, M.S., Benjamin, D.K. Jr., Smith, P.B., The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol 42 (2015), 105–117 viii–ix.
5. Pinhat, E.C., Borba, M.G., Ferreira, M.L., et al. Fungal colonization in newborn babies of very low birth weight: a cohort study. J Pediatr (Rio J) 88 (2012), 211–216.
6. Benjamin, D.K. Jr., Stoll, B.J., Gantz, M.G., et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 126 (2010), e865–e873.
7. Ghazal, P., Dickinson, P., Smith, C.L., Early life response to infection. Curr Opin Infect Dis 26 (2013), 213–218.
8. Brady, M.T., Health care-associated infections in the neonatal intensive care unit. Am J Infect Control 33 (2005), 268–275.
9. Izquierdo, G., Santolaya, M.E., Invasive candidiasis in newborns: diagnosis, treatment and prophylaxis. Rev Chilena Infectol 31 (2014), 73–83.
10. Wynn, J.L., Benjamin, D.K. Jr., Benjamin, D.K., Cohen-Wolkowiez, M., Clark, R.H., Smith, P.B., Very late onset infections in the neonatal intensive care unit. Early Hum Dev 88 (2012), 217–225.
11. Benjamin, D.K. Jr., Stoll, B.J., Fanaroff, A.A., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117 (2006), 84–92.
12. Adams-Chapman, I., Bann, C.M., Das, A., et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr, 163, 2013 961–967.e3.
13. Blyth, C.C., Chen, S.C., Slavin, M.A., et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 123 (2009), 1360–1368.
14. Santolaya, M.E., Alvarado, T., Queiroz-Telles, F., et al. Active surveillance of candidemia in children from Latin America: a key requirement for improving disease outcome. Pediatr Infect Dis J 33 (2014), e40–e44.
15. Hope, W.W., Castagnola, E., Groll, A.H., et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect 18:Suppl. 7 (2012), 38–52.
16. Santolaya, M.E., Alvarado Matute, T., de Queiroz Telles, F., et al. Recommendations for the management of candidemia in neonates in Latin America. Grupo Proyecto Epico. Rev Iberoam Micol 30:Suppl. 1 (2013), 158–170.
17. Figueras, C., Diaz de Heredia, C., Garcia, J.J., et al. The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis. An Pediatr (Barc), 74, 2011 337.e1–e17.
18. Pappas, P.G., Kauffman, C.A., Andes, D.R., et al. Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62 (2016), e1–e50.
19. Kimberlin, D.W., (eds.) Red Book – Report of the Committee on Infectious Diseases, 2015.
20. Murad, M.H., Montori, V.M., Ioannidis, J.P.A., et al. How to read a systematic review and meta-analysis and apply the results to patient care. Users’ guides to the medical literature. JAMA 312 (2014), 171–179.
21. Uko, S., Soghier, L.M., Vega, M., et al. Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants. Pediatrics 117 (2006), 1243–1252.
22. Manzoni, P., Arisio, R., Mostert, M., et al. Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study. Pediatrics 117 (2006), e22–e32.
23. Weitkamp, J.H., Ozdas, A., LaFleur, B., Potts, A.L., Fluconazole prophylaxis for prevention of invasive fungal infections in targeted highest risk preterm infants limits drug exposure. J Perinatol 28 (2008), 405–411.
24. Healy, C.M., Campbell, J.R., Zaccaria, E., Baker, C.J., Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole resistant Candida species. Pediatrics 121 (2008), 703–710.
25. Rueda, K., Moreno, M.T., Espinosa, M., Saez-Llorens, X., Impact of routine fluconazole prophylaxis for premature infants with birth weights of less than 1250 grams in a developing country. Pediatr Infect Dis J 29 (2010), 1050–1052.
26. Kaufman, D.A., Morris, A., Gurka, M.J., Kapik, B., Hetherington, S., Fluconazole prophylaxis in preterm infants: a multicenter case–controlled analysis of efficacy and safety. Early Hum Dev 90:Suppl. 1 (2014), S87–S90.
27. Rolnitsky, A., Levy, I., Sirota, L., Shalit, I., Klinger, G., Targeted fluconazole prophylaxis for high-risk very low birth weight infants. Eur J Pediatr 171 (2012), 1481–1487.
28. Cetinkaya, M., Ercan, T.E., Saglam, O.K., Buyukkale, G., Kavuncuoglu, S., Mete, F., Efficacy of prophylactic fluconazole therapy in decreasing the incidence of Candida infections in extremely low birth weight preterm infants. Am J Perinatol 31 (2014), 1043–1048.
29. Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., Donowitz, L.G., Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345 (2001), 1660–1666.
30. Parikh, T.B., Nanavati, R.N., Patankar, C.V., et al. Fluconazole prophylaxis against fungal colonization and invasive fungal infection in very low birth weight infants. Indian Pediatr 44 (2007), 830–837.
31. Benjamin, D.K. Jr., Hudak, M.L., Duara, S., et al. Effect of fluconazole prophylaxis on candidiasis and mortality in premature infants: a randomized clinical trial. JAMA 311 (2014), 1742–1749.
32. Manzoni, P., Stolfi, I., Pugni, L., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356 (2007), 2483–2495.
33. Greenberg, R.G., Benjamin, D.K. Jr., Neonatal candidiasis: diagnosis, prevention, and treatment. J Infect 69:Suppl. 1 (2014), S19–S22.
34. Kaufman, D., Boyle, R., Hazen, K.C., Patrie, J.T., Robinson, M., Grossman, L.B., Twice weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight. J Pediatr 147 (2005), 172–179.
35. Pappas, P.G., Kauffman, C.A., Andes, D., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 62 (2015), e1–e50.
36. Healy, C.M., Baker, C.J., Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J 28 (2009), 49–52.
37. Austin, N., Darlow, B.A., McGuire, W., Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev, 2009, CD003478.
38. Clerihew, L., Austin, N., McGuire, W., Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev, 2007, CD003850.
39. Clerihew, L., Austin, N., McGuire, W., Systemic antifungal prophylaxis for very low birthweight infants: a systematic review. Arch Dis Child Fetal Neonatal Ed 93 (2008), F198–F200.
40. McGuire, W., Clerihew, L., Austin, N., Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev, 2004, CD003850.
41. Mohan, P., Eddama, O., Weisman, L.E., Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units. Cochrane Database Syst Rev, 2007, CD006068.
42. Zhang, J.P., Chen, C., Meta-analysis of the efficacy and safety of fluconazole in prophylaxis of fungal infection in very low birth weight infants. Zhonghua Er Ke Za Zhi 47 (2009), 743–891.
43. Tripathi, N., Watt, K., Benjanin, D.K. Jr., Treatment and prophylaxis of invasive candidiasis. Semin Perinatol 36 (2012), 416–423.